Long QT syndrome with a high mortality rate caused by a novel G572R missense mutation in KCNH2

Clinical Genetics

Volumn 57, Issue 2, 2000, Pages 125-130

  Larsen, Lars Allan ^a   Svendsen, Ida Hastrup ^b,c   Jensen, Annette Møller ^c,d   Kanters, Jørgen K ^d,e   Andersen, Paal Skytt ^a   Møller, Mogens ^f   Sørensen, Sven Asger ^d   Sandøe, Erik ^c   Jacobsen, Joes Ramsøe ^c   Vuust, Jens ^a   Christiansen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Elsinore Hospital   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

HERG; Jervell and Lange Nielsen syndrome; KVLQT1; Romano Ward syndrome; Sudden death; Ventricular tachycardia

Indexed keywords

ARGININE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCINE; POTASSIUM CHANNEL;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; AROUSAL; ARTICLE; CHANNEL GATING; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FEMALE; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; MALE; MISSENSE MUTATION; MORTALITY; POTASSIUM CURRENT; PRIORITY JOURNAL; SYNCOPE; T WAVE; TORSADE DES POINTES;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CATION TRANSPORT PROTEINS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ETHER-A-GO-GO POTASSIUM CHANNELS; FATAL OUTCOME; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEDIGREE; PHENOTYPE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATORS;

EID: 0034003508     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2000.570206.x     Document Type: Article

References (36)

1. Schwartz PJ, Locati EH, Napolitano C. The long QT syndrome. In: Zipes DP. Jalife J, eds. Cardiac Electrophysiology. From Cell to Bedside. Philadelphia: Saunders. 1995: 788.
2. Wang Q. Curran ME, Splawski I et al. Positional cloning of a novel potassium channel gene: KVLQTI mutations cause cardiac arrhythmias. Nat Genet 1996: 12: 17-23.
3. Neyroud N, Tesson F, Denjoy I et al. A novel mutation in the potassium channel gene KVLQTI cause the Jervell and Lange Nielsen cardioauditory syndrome. Nat Genet 1997: 15: 186-189.
4. + -channel dysfunction in an inherited cardiac arrhytmia. Proc Natl Acad Sci USA 1996: 93: 2208-2212.
5. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrythmia: HERG mutations cause long QT syndrome. Cell 1995: 80: 795-803.
6. Duggal P, Vesely MR, Wattanasirichaigoon D, Villafane J, Kaushik V, Beggs AH. Mutations of the gene for IsK associated with both Jervell and Lange Nielsen and Romano Ward forms of long QT syndrome. Circulation 1998: 97: 142-146.
7. Splawski I, Tristani-Firouzi M, Lehmann MH. Sanguinetti MC, Keating MT. Mutations of the gene cause long QT syndrome and suppress Iks function. Nat Genet 1997: 17: 338-340.
8. kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999: 97: 175-187.
9. Wang Q, Shen J, Splawski I et al. SCN5A mutations associated with an inherited cardiac arrhythmia. long QT syndrome. Cell 1995: 80: 805-811.
10. Chen Q, Kirsch GE, Zhang D et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998: 392; 293-296.
11. Schott JJ, Charpentier F, Peltier S et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995: 57: 1114-1122.
12. LQTSdbase. http: www.ssi.dk en forskning lqtsdb lqtsdb.htm.
13. Berthet M, Denjoy I, Donger C et al. C-terminal HERG mutations: the role of hypokalemia and a KCNQI-associated mutation in the cardiac event occurrence. Circulation 1999: 99: 1464-1470.
14. Chen J, Zou A, Splawski I, Keating MT, Sanguinetti MC. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem 1999: 274: 10113-10118.
15. Jongbloed RJ, Wilde AA, Geelen JL et al. Novel KCNQI and HERG missensc mutations in Dutch long QT families. Hum Mutat 1999: 13: 301-310.
16. Larsen LA. Christiansen M, Vuust J, Andersen PS. High-throughput single-strand conformation polymorphism analysis by automated capillary electrophoresis: robust multiplex analysis and pattern-based identification of allelic variants. Hum Mutat 1999: 13: 318-327.
17. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long QT syndrome: clinical impact. Circulation 1999: 99: 529-533.
18. Itoh T, Tanaka T, Nagai R et al. Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome. Hum Genet 1998: 102: 435-439.
19. Satler CA, Vesely MR, Duggal P, Ginsburg GS, Beggs AH. Multiple different missense mutations in the pore region of HERG in patients with long QT syndrome. Hum Genet 1998: 102: 265-272.
20. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three long QT syndrome genes: KVLQTI, HERG, and KCNEI. Genomics 1998: 51: 86-97.
21. Tanaka T, Nagai R, Tomoike H et al. Four novel KVLQTI and four novel HERG mutations in familial long QT syndrome. Circulation 1997: 95: 565-567.
22. Benson DW, MacRae CA, Vesely MR et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation 1996: 93: 1791-1795.
23. Dausse E, Berthet M, Denjoy I et al. A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol 1996: 28: 1609-1615.
24. Satler CA, Walsh EP, Vesely MR, Plummer MH, Ginsburg GS, Jacob HJ. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am J Med Genet 1996: 65: 27-35.
25. Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 1994: 91: 3438-3442.
26. + channels expressed in Xenopus oocytes. Am J Physiol 1997: 272: H1309-H1314.
27. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920: 7: 357-370.
28. + -channel by mutation of the H5 region. Nature 1991: 349: 700-704.
29. Wilde AA, Jongbloed RJ, Doevendans PA et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQTI-related patients (LQTS1), J Am Coll Cardiol 1999: 33: 327-332.
30. Zareba W, Moss AJ, Schwartz PJ et al. Influence of genotype on the clinical course of the long QT syndrome. International long QT syndrome registry research group. N Engl J Med 1998: 339: 960-965.
31. Rasmussen LH, Andersen T. The relationship between QTC changes and nutrition during weight loss after gastroplasty. Acta Med Scand 1985: 217: 271-275.
32. Vervaet P, Amery W. QTC measurements: a case-control study on serum electrolytes. Acta Cardiol 1993: 48: 565-578.
33. Tanaka T, Itoh T, Nagai R, Yazaki Y, Nakamura Y. Mutational analysis of familial long QT syndrome: implication of correlation between mutated gene and response to beta-adrenergic blocking agent. Am J Hum Genet 1997: 61 (Suppl.): A115.
34. Compton SJ, Lux RL, Ramsey MR et al. Genetically defined therapy of inherited long QT syndrome. Correction of abnormal repolarization by potassium. Circulation 1996: 94: 1018-1022.
35. + - channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the Long QT syndrome. Circ Res 1996: 78: 1009-1015.
36. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation 1997: 96: 2038-2047.